Federal Research Institute of Pediatric Hematology, Oncology and Immunology clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 2/3 | 3 | |
| Phase 3 | 5 | |
| Phase 4 | 1 |
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Leukemia (7) · Acute Lymphoblastic Leukemia (ALL) (6) · Acute Myeloid Leukemia (AML) (5) · Myelodysplastic Syndromes (MDS) (2) · Non-Hodgkin Lymphoma (2) · DLBCL (1) · Liver Cancer (1)
Get alerts when Federal Research Institute of Pediatric Hematology, Oncology and Immunology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.